Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,608,100 | 4,939,600 | 4,972,200 | 4,674,700 | 4,569,600 |
| Marketable Securities | N/A | 1,347,400 | 1,410,600 | 1,526,500 | 1,546,300 |
| Receivables | 2,052,800 | 1,946,400 | 1,893,500 | 1,805,100 | 1,609,400 |
| Inventories | 1,686,800 | 1,626,800 | 1,499,300 | 1,359,700 | 1,205,400 |
| TOTAL | $11,201,000 | $10,569,600 | $10,427,900 | $10,008,800 | $9,596,400 |
| Non-Current Assets | |||||
| PPE Net | 1,520,300 | 1,425,100 | 1,335,100 | 1,295,900 | 1,227,800 |
| Investments And Advances | 5,712,300 | 5,722,800 | 5,645,900 | 5,156,500 | 5,107,900 |
| Intangibles | 0 | 1,517,800 | 1,523,500 | 1,529,200 | 1,913,900 |
| Other Non-Current Assets | 7,209,400 | 5,627,000 | 5,104,300 | 4,890,100 | 4,687,200 |
| TOTAL | $14,442,000 | $14,292,700 | $13,608,800 | $12,871,700 | $12,936,800 |
| Total Assets | $25,643,000 | $24,862,300 | $24,036,700 | $22,880,500 | $22,533,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,432,900 | 420,300 | 442,300 | 445,000 | 413,000 |
| Accrued Expenses | N/A | 3,613,500 | 3,270,700 | 2,951,800 | 2,788,600 |
| Other current liabilities | 428,300 | 441,500 | 425,400 | 386,400 | 363,000 |
| TOTAL | $3,861,200 | $4,475,300 | $4,138,400 | $3,783,200 | $3,564,600 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,116,000 | 3,068,200 | 2,722,900 | 2,489,600 | 2,559,000 |
| TOTAL | $3,116,000 | $3,068,200 | $2,722,900 | $2,601,000 | $2,559,000 |
| Total Liabilities | $6,977,200 | $7,543,500 | $6,861,300 | $6,384,200 | $6,123,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 253,719 | 256,391 | 256,797 | 256,790 |
| Common Shares | N/A | 2,500 | 2,600 | 2,600 | 2,600 |
| Retained earnings | N/A | 12,368,900 | 11,286,000 | 10,253,100 | 9,606,800 |
| Other shareholders' equity | 18,665,800 | -64,500 | -101,100 | 68,100 | 127,800 |
| TOTAL | $18,665,800 | $17,318,800 | $17,175,400 | $16,496,300 | $16,409,600 |
| Total Liabilities And Equity | $25,643,000 | $24,862,300 | $24,036,700 | $22,880,500 | $22,533,200 |